Zartra
Active substance: imiquimod
imiquimod
Centralised EU authorisationWithdrawn
Marketing holder: Laboratoires 3M Santé
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 14 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-71de-77dd-8a50-27e3b5dd2f98,01a1208c-fdd3-77f7-843b-c85d41ebb8b2,01a1208d-f492-7b16-96f9-d99fde0dd9ba,01a1208e-f23c-7f93-9e5b-4fdcf1551d1e,01a12091-6764-7d0a-8c0a-d4deb4f3a5ad;count=14 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000180
- Registration status
- Withdrawn
- ATC code
- L03AX
Sources
- product · EMA · EMEA/H/C/000180 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000180 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000180 · Verified 2026-10-09